Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors

SIMPLE SUMMARY: The medical care for patients with neuroendocrine tumors arising from the intestines, pancreas, or stomach is frequently limited by the development resistance to common treatment approaches including targeted therapies and chemotherapy. The purpose of this review is to summarize the...

Descripción completa

Detalles Bibliográficos
Autores principales: McClellan, Kristen, Chen, Emerson Y., Kardosh, Adel, Lopez, Charles D., Del Rivero, Jaydira, Mallak, Nadine, Rocha, Flavio G., Koethe, Yilun, Pommier, Rodney, Mittra, Erik, Pegna, Guillaume J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563314/
https://www.ncbi.nlm.nih.gov/pubmed/36230691
http://dx.doi.org/10.3390/cancers14194769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563314/
https://www.ncbi.nlm.nih.gov/pubmed/36230691
http://dx.doi.org/10.3390/cancers14194769

Ejemplares similares